tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Bausch + Lomb Reports Q2 2025 Revenue Growth, Raises Full-Year Guidance

Story Highlights
Bausch + Lomb Reports Q2 2025 Revenue Growth, Raises Full-Year Guidance

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Bausch + Lomb Corporation ( (BLCO) ) just unveiled an announcement.

Bausch + Lomb reported a revenue of $1.278 billion for the second quarter of 2025, marking a 5% increase from the previous year, driven by strong performance in its Vision Care segment. Despite a GAAP net loss of $62 million, the company raised its full-year guidance, reflecting solid business performance and the impact of foreign exchange. The company resumed full production of its enVista intraocular lenses following a voluntary recall and achieved significant growth in its dry eye portfolio, showcasing its robust pipeline and future potential.

The most recent analyst rating on (BLCO) stock is a Buy with a $18.00 price target. To see the full list of analyst forecasts on Bausch + Lomb Corporation stock, see the BLCO Stock Forecast page.

Spark’s Take on BLCO Stock

According to Spark, TipRanks’ AI Analyst, BLCO is a Neutral.

Bausch + Lomb’s stock score is primarily influenced by its financial performance and technical analysis. While the company shows strong market positioning and growth in key segments, profitability and cash flow issues weigh heavily. Technical indicators are favorable, but nearing overbought levels. The valuation remains weak, primarily due to negative earnings. However, recent corporate events and resilient earnings call outcomes provide some positive outlook.

To see Spark’s full report on BLCO stock, click here.

More about Bausch + Lomb Corporation

Bausch + Lomb Corporation is a leading global eye health company focused on helping people see better to live better. The company offers a wide range of products including contact lenses, intraocular lenses, and pharmaceuticals, with a strong market presence in vision care and surgical segments.

Average Trading Volume: 828,863

Technical Sentiment Signal: Hold

Current Market Cap: $5.1B

See more data about BLCO stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1